PROMEDIOR
Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, an... d greatly reduce the risk of systemic side effects inherent in current therapeutic approaches. Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.
PROMEDIOR
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.promedior.com
Total Employee:
51+
Status:
Active
Contact:
781-538-4200
Email Addresses:
[email protected]
Total Funding:
63 M USD
Technology used in webpage:
Viewport Meta Domain Not Resolving SPF Google Maps Mobile Non Scaleable Content IPv6 Microsoft Mimecast Akamai DNS
Similar Organizations
Acologix
Acologix is a biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Baergic Bio
Baergic Bio is a biopharmaceutical company that develops and commercialises novel therapeutics for the treatment of CNS disorders.
Complexa
Complexa, a biopharmaceutical company, develops therapies for the treatment of inflammatory, and metabolic diseases.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
ReVision Therapeutics
ReVision Therapeutics, a biopharmaceutical company, develops drugs for the treatment of age-related macular degeneration diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Promedior
Shire
Shire investment in Series D - Promedior
HealthCare Ventures
HealthCare Ventures investment in Series D - Promedior
Forbion Capital Partners
Forbion Capital Partners investment in Series D - Promedior
Fibrotic Ventures
Fibrotic Ventures investment in Series D - Promedior
Polaris Partners
Polaris Partners investment in Series D - Promedior
Morgenthaler Ventures
Morgenthaler Ventures investment in Series D - Promedior
Easton Capital
Easton Capital investment in Series D - Promedior
Easton Capital
Easton Capital investment in Series D - Promedior
Fibrotic Ventures
Fibrotic Ventures investment in Series D - Promedior
Official Site Inspections
http://www.promedior.com
- Host name: p16andki67.com
- IP address: 198.21.19.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Promedior"
Promediol โ Swiss Therapeutic Solutions
Promediol SA is a Swiss company focused on health and quality of life. Our headquarter is located in canton Ticino, in the heart of Switzerland and Europe, just a few hours from France, Italy and Germany, and we have partnerships โฆSee details»
Promedior - Crunchbase Company Profile & Funding
Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseasesSee details»
Promedior Company Profile 2024: Valuation, Investors ... - PitchBook
Promedior General Information Description. Developer of therapeutics designed to treat fibrotic diseases. The company is focused on rare fibrotic diseases including idiopathic pulmonary โฆSee details»
Promedior | VentureRadar
IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be safer than and additive to other anti-fibrotic therapeutic โฆSee details»
Promedior - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โฆSee details»
Promedior, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Promedior, Inc. of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Promedior - Crunchbase
Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.See details»
Promedior - EquityNet
Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug โฆSee details»
Promedior Inc - News, Articles etc. - European Pharmaceutical โฆ
Sep 2, 2015 news BMS gets exclusive rights to acquire Promedior. 2 September 2015 | By Victoria White As well as granting exclusive rights to acquire Promedior, the agreement grants โฆSee details»
Promediol SA
[email protected] - the deletion of the data in our archives (so-called right to be forgotten), by noti๏ฌcation to +41919803945, [email protected] - to restrict the processing of data in โฆSee details»
Roche closes $390M acquisition of private biotech firm Promedior
Feb 13, 2020 Roche Holding AG closed its acquisition with private biotech firm Promedior Inc. for $390 million, adding a potential lung fibrosis drug to its portfolio.. The Lexington, Mass. โฆSee details»
Promedior Culture - Comparably
Learn about Promedior's culture, see what work's like, read reviews, and find job opportunities.See details»
BUGIARDINO PROMEDIOL FULL SPECTRUM
Apresentação de Promediolโข ® CBD Full Spectrum. O produto é embalado em frascos de 10 ml ou 30 ml com as seguintes concentrações médias: Promediolโข Organismos® CBD Full โฆSee details»
ROTEIRO PARA ORIENTAÇÃO NA PRESCRIÇÃO DE PRODUTO À โฆ
Promediol do Brasil Rua Clóvis Soares, 200 sala 506, Edificio Itália +55 11 3402 3911 | Atibaia โ SP |CEP 12.942-560 www.promediol.com [email protected] FALE CONOSCO โฆSee details»
My Account
Access and manage your Microsoft account and organizations.See details»
Extrato de Cannabis Promediol 200mg/ml Solução Gotas 10ml
Encontre Extrato de Cannabis Promediol 200mg/ml Solução Gotas 10ml com o menor preço na Droga Raia, sua farmácia online 24 horas. Retire seu pedido na loja ou receba-o em casa! โฆSee details»
EXTRATO DE CANNABIS SATIVA PROMEDIOL 10 ML - Biolab
7898994979807 EXTRATO DE CANNABIS SATIVA PROMEDIOL 200MG/ML SOL GOT 10 ML Cannabis Sativa L. Solução gotas Solução gotas de extrato de Cannabis sativa L. a 20% (200 โฆSee details»
Extrato de Cannabis Sattiva Promediol Full Spectrum 200mg - 30ml
Não interrompa o uso do extrato de Cannabis sativa Promediol sem o conhecimento do seu médico. Advertências: Pacientes com histórico de hipersensibilidade e alergia a qualquer um โฆSee details»
Promedió | Spanish to English Translation - SpanishDictionary.com
Translate Promedió. See 4 authoritative translations of Promedió in English with example sentences, conjugations and audio pronunciations.See details»
Bula do Extrato de Cannabis sativa Promediol - Consulta Remédios
Extrato de Cannabis sativa deve ser administrado por via oral com o auxílio do gotejador, junto com alimentos para melhor absorção do produto.. Para administrar este produto, realize esta โฆSee details»